Skip to main content

Table 1 Overview of patient sample characteristics

From: Development and content validation of the Symptoms Evolution of COVID-19: a patient-reported electronic daily diary in clinical and real-world studies

  N = 30
Age (years), mean (SD) 45.03 (19.39)
Gender, n (%)
 Male 12 (40)
 Female 18 (60)
Race, n (%)
 White 26 (86.7)
 Other 4 (13.3)
Education level, n (%)
 Secondary 15 (50)
 National vocational or work-related qualification 1 (3)
 Degree or higher 14 (47)
Number of days between diagnosis and interview, mean (SD) 12.40 (5.29)
Number of days since symptoms began, mean (SD) 19.17 (7.96)
Number of days between symptoms began and diagnosis, mean (SD) 6.77 (7.96)
General health ratings, n (%)
 Excellent 6 (20)
 Very good 8 (26.7)
 Good 4 (13.3)
 Fair 9 (30)
 Poor 3 (10)
Comorbiditiesa, n (%) 17 (57)
  1. aComorbidities across sample include: cardiovascular disease (e.g., heart failure, coronary artery disease, cardiomyopathy, pulmonary hypertension, pulmonary fibrosis), hypertension, diabetes (e.g., type 1, type 2, gestational), chronic obstructive pulmonary disease, chronic kidney disease, cancer, stickle cell disease, metabolic dysfunction-associated fatty liver disease, chronic liver disease (e.g., cirrhosis), history of stroke, thalassemia